• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
SNY

SNY

Sanofi

NASDAQHealthcareDrug Manufacturers - GeneralFR

USD42.37

-0.43 (-1.00%)

Rating:A

Company Profile

CEO

Olivier Charmeil

IPO Date

2002-07-01

Sector

Healthcare

Industry

Drug Manufacturers - General

Exchange

NASDAQ

Country

FR

Market Metrics

Open

$42.56

Prev. Close

$42.80

Day Low

$42.37

Day High

$42.74

52W Low

$42.28

52W High

$52.68

Market Cap

$102.04B

Volume

2.45M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

48.4%

Avg Negative

2.9%

Avg Neutral

48.5%

News Feed

Sanofi SA (SNY) CEO Paul Hudson on Q2 2021 Results - Earnings Call Transcript

Seeking Alpha·7/29/2021·↓ negative

Sanofi (SNY) Q2 Earnings & Sales Beat, 2021 EPS View Raised

Zacks Investment Research·7/29/2021·↑ positive

Online availability of Sanofi's half-year financial report for 2021

GlobeNewsWire·7/29/2021·↓ negative

Sanofi Q2 Performance Benefits From Dupixent, Vaccines; Raises 2021 Profit Forecast

Benzinga·7/29/2021·↑ positive

Sanofi raises profit forecasts after strong second quarter

Reuters·7/29/2021·↑ positive

Sanofi's Pompe Disease Enzyme Replacement Therapy Gets EMA's CHMP Backing

Benzinga·7/27/2021·↑ positive

15 European Dividend Aristocrats to Diversify Your Portfolio

InvestorPlace·7/21/2021·↓ negative

EMA Starts Rolling Review Of Glaxo - Sanofi COVID-19 Vaccine

Benzinga·7/20/2021·↑ positive

Sanofi's Oral Treatment For Sleeping Sickness Gets FDA Approval

Benzinga·7/19/2021·↑ positive

Sanofi announces Paris 2024 Premium partnership for the Olympic and Paralympic Games in Paris

GlobeNewsWire·7/13/2021·↑ positive